PharmaEngine Inc operates within the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares PharmaEngine Inc with three other
companies in this sector in Taiwan:
Unicocell Biomed Co Ltd
sales of 1.00 billion Taiwanese Dollars [US$33.05 million]
Medigen Biotechnology Corporation
(399.89 million Taiwanese Dollars [US$13.18 million]
of which 81%
was Drug Discovery), and
Sofiva Genomics Co Ltd
(383.95 million Taiwanese Dollars [US$12.65 million]
During the year ended December of 2016, sales at
PharmaEngine Inc were 1.13 billion Taiwanese Dollars (US$37.39 million).
increase of 123.7%
versus 2015, when the company's sales were 507.24 million Taiwanese Dollars.
This was the third consecutive year of growth at PharmaEngine Inc.